FNY Investment Advisers’s Global Blood Therapeutics, Inc. GBT Stock Holding History

FNY Investment Advisers’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,300	Closed	-$1.18M	–	904
2022 Q3	$1.18M	Buy	+17,300	New	+$954K	0.82%	32
2019 Q3	–	Sell	-19,288	Closed	-$1.01M	–	1248
2019 Q2	$1.01M	Buy	+19,288	New	+$1.11M	0.3%	42
2018 Q4	–	Sell	-5,000	Closed	-$190K	–	1128
2018 Q3	$190K	Buy	5,000 +871	+21%	+$38.6K	0.04%	197
2018 Q2	$186K	Buy	+4,129	New	+$188K	0.07%	165

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

FNY Investment Advisers's GBT Position: Q4 2022 in Review

FNY Investment Advisers sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 17,300 shares — an estimated $1.18M sold.

FNY Investment Advisers first reported a position in GBT in Q2 2018 and held it in 4 quarters. The position peaked at $1.18M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

FNY Investment Advisers reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
FNY Investment Advisers sold 17,300 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.18M.
FNY Investment Advisers first reported a position in Global Blood Therapeutics, Inc. in Q2 2018 and held it in 4 quarters.
FNY Investment Advisers's Global Blood Therapeutics, Inc. position peaked at $1.18M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on FNY Investment Advisers's 13F filing for Q4 2022, filed 10 Jan 2023.